Endovascular Engineering Secures $80M to Advance VTE Treatment

Endovascular Engineering raises an oversubscribed $80 million in Series C financing to advance the treatment of venous thromboembolism (VTE).

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here